Postoperative Residual Curarization: Clinical Trials

4 trials for Postoperative Residual Curarization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Unknown 1

Follow Postoperative Residual Curarization: new trials by email Literature Review of Postoperative Residual Curarization trials Research Report on Postoperative Residual Curarization

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
Sugammadex, Neostigmine - Kidney Transplant; Complications, Postoperative Residual Curarization
Phase 4CompletedUniversity of Colorado, Denver842021-02-022025-05-22
Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac Surgery
Sugammadex - Postoperative Residual Curarization, Neuromuscular Block
Phase 4UnknownThe Hospital of Vestfold1442018-08-012018-05-30
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
Neostigmine, Sugammadex - Neuromuscular Blockade, Sugammadex
Phase 4CompletedKartal Kosuyolu Yuksek Ihtisas Education and Research Hospital1132013-05-012021-10-04
Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia
Cisatracurium, Rocuronium - Postoperative Residual Curarization, Residual Neuromuscular Block
Phase 4CompletedAzienda Ospedaliera di Padova1202012-07-012014-03-11

Narrower conditions

Delayed Emergence from Anesthesia (4)

Broader conditions

Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Postoperative Complications (4)

Interventions

Sugammadex (3)  ·  Neostigmine (2)  ·  Rocuronium (1)  ·  cisatracurium (1)

Sponsors

Azienda Ospedaliera di Padova (1)  ·  Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital (1)  ·  The Hospital of Vestfold (1)  ·  University of Colorado, Denver (1)

Countries

Italy (1)  ·  United States (1)

Top investigators

Ana Fernandez-Bustamante, M.D., Ph.D. (1)  ·  Carlo Ori, Prof. M.D. (1)  ·  Paolo Feltracco, M.D. (1)

Results publications

PMID 20876699, PMID 20885293, PMID 26634077, PMID 28399799, PMID 41833179